(Q41479099)

1 October 2017

title

B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. (English)

1 reference

1 October 2017

6

Banchereau J

1 reference

1 October 2017

van Kooten C

1

1 reference

1 October 2017

Gaillard C

2

1 reference

1 October 2017

Galizzi JP

3

1 reference

1 October 2017

Hermann P

4

1 reference

1 October 2017

Fossiez F

5

1 reference

1 October 2017

Blanchard D

7

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

European Journal of Immunology

1 October 2017

published in

1 reference

1 October 2017

volume

24

1 reference

1 October 2017

issue

4

1 reference

1 October 2017

page(s)

787-792

1 reference

Cognate interactions between helper T cells and B cells

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

The T cell receptor/CD3 complex: a dynamic protein ensemble

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Regulation of human B-cell activation and adhesion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

A new superfamily of cell surface proteins related to the nerve growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Mechanism of antigen-driven selection in germinal centres

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Identification of a source of biologically active CD40 ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Expression of a 32‐kDa ligand for the CD40 antigen on activated human T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Molecular and biological characterization of a murine ligand for CD40

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Cloning of TRAP, a ligand for CD40 on human T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Germinal centres in T-cell-dependent antibody responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Activation of human B lymphocytes through CD40 and interleukin 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

CD40 ligand is a T cell growth factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Shedding of tumor necrosis factor receptors by activated human neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Identification of a truncated form of the nerve growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Isolated human follicular dendritic cells display a unique antigenic phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

The distinct surface of human blood dendritic cells, as observed after an improved isolation method

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240402

7 January 2021

Identifiers

DOI

10.1002/EJI.1830240402

1 reference

1 October 2017

1 reference